| scholarly article | Q13442814 |
| P50 | author | James Lewis Abbruzzese | Q14947937 |
| Isaiah J. Fidler | Q56221878 | ||
| P2093 | author name string | Do-Hyun Nam | |
| Stanley R Hamilton | |||
| Sun-Jin Kim | |||
| Premal H Thaker | |||
| Junqin He | |||
| Kenji Yokoi | |||
| Sertac Yazici | |||
| Robert R Rebhun | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| colon carcinoma | Q18554829 | ||
| P304 | page(s) | 3716-3725 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model | |
| P478 | volume | 65 |
| Q39473604 | A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment. |
| Q58716670 | ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells |
| Q37688993 | Age and cellular context influence rectal prolapse formation in mice with caecal wall colorectal cancer xenografts. |
| Q37575028 | Anaplastic thyroid cancer, tumorigenesis and therapy |
| Q46856380 | Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration |
| Q33575434 | Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model |
| Q46630704 | Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice |
| Q36521850 | Biological agents versus chemotherapy in the treatment of colorectal cancer |
| Q37921797 | Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look? |
| Q36565941 | Clinical implications of the mechanism of epidermal growth factor receptor inhibitors |
| Q36764012 | Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer |
| Q37204970 | Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications |
| Q37613493 | Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? |
| Q34768516 | Construction of a novel constitutively active chimeric EGFR to identify new targets for therapy |
| Q49470056 | Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer |
| Q37639541 | Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery. |
| Q39844354 | Design and manufacture of a novel system to simulate the biomechanics of basic and pitching shoulder motion |
| Q40079882 | Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines. |
| Q24615472 | Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma |
| Q36866617 | Emerging drugs for the treatment of pancreatic cancer |
| Q33869014 | Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas |
| Q33317631 | Healing potential of Picrorhiza kurroa (Scrofulariaceae) rhizomes against indomethacin-induced gastric ulceration: a mechanistic exploration |
| Q36179928 | Hypoestoxide inhibits tumor growth in the mouse CT26 colon tumor model |
| Q36259629 | Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice |
| Q33594662 | MicroRNA-192 suppresses liver metastasis of colon cancer |
| Q83956989 | Minimally invasive colorectal resection is associated with a rapid and sustained decrease in plasma levels of epidermal growth factor (EGF) in the colon cancer setting |
| Q38705019 | Modeling of Patient-Derived Xenografts in Colorectal Cancer |
| Q36734908 | Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model |
| Q36481002 | Molecular biology of epidermal growth factor receptor inhibition for cancer therapy |
| Q37132173 | Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer |
| Q38627347 | Multifunctional receptor-targeting antibodies for cancer therapy |
| Q34382785 | New approaches in angiogenic targeting for colorectal cancer. |
| Q36879141 | Panitumumab in colorectal cancer |
| Q35154233 | Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients |
| Q24644787 | Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors |
| Q47444314 | Potential of Cationic-Polymeric Nanoparticles for Oral Delivery of Naringenin: In Vitro and In Vivo Investigations |
| Q47758650 | R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis |
| Q37077828 | Rationale for combining biotherapy in the treatment of advanced colon cancer. |
| Q36627254 | Recent developments in colorectal cancer treatment by monoclonal antibodies |
| Q35060325 | Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis |
| Q40005161 | Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy. |
| Q47445868 | The anti-proliferative side effects of AEE788, a tyrosine kinase inhibitor blocking both EGF- and VEGF-receptor, are liver-size-dependent after partial hepatectomy in rats |
| Q38132400 | The role of epidermal growth factor receptor in cancer metastasis and microenvironment |
| Q36677407 | VEGF/VEGFR signalling as a target for inhibiting angiogenesis |
Search more.